Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines.

As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients.

We offer a large selection of services for all types of biopharmaceuticals, including proteins, peptides, peptides, nucleic acids, gene- and cell therapy products, vaccines and virus(-like) particles up to biosafety level S2.

Formulation research and development
    (from pre-formulation to market formulations)

Analytical method development
    (aggregate and particle characterization, protein analytics, GMP analytics)

Forced degradation and stability testing
    (stress conditions tailored for the product, stability testing according ICH)

Lyophilization
    (cycle development, scale up, modern PAT-tools)

Supply of pre-clinical material
    (GMP-like conditions in clean room)


Pharmaceutical

Biotechnology

Coriolis Pharma

Silvia Steyrer-Gruber

Frank Schaubhut

Andrea Hawe

The Leadership Team at Coriolis Pharma is responsible for strategic decision-making and overall direction of the company. They oversee the integration of scientific innovation and operational efficiency, ensuring that the company remains at the forefront of formulation research and development in (bio)pharmaceuticals. This team also fosters collaboration among interdisciplinary experts to deliver high-quality, tailor-made solutions for clients while maintaining compliance with industry standards.

Leadership Team

About

Team members

Other teams at Coriolis Pharma

Scientific Research and Development

Project Management